⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 26, 2007Expert Opinion on Investigational Drugs

Therapeutical potential of direct thrombin inhibitors for atherosclerotic vascular disease

View Full Paper

Ask AI

Bookmark

Share

Design

Review

Authors

MHMarc HusmannCenter for Pediatric Endocrinology Zurich MBMatthias BartonPreventive Cardiology

Discussion

Loading...

Member takes

Implication

Should not change practice for atherothrombotic disease; leaves open the role of direct thrombin inhibitors pending randomized trials.

Structured PICO

I

Intervention

Direct thrombin inhibitors

Orally active direct thrombin inhibitors represent a promising therapeutic option for the long-term management and prevention of atherothrombotic complications.

Cite This Study

Husmann et al. (2007) studied this question.

synapsesocial.com/papers/6a80e376046b5fb0cc646b66 https://doi.org/10.1517/13543784.16.5.563

Topics

Dual antiplatelet therapy

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Antithrombotic treatment for peripheral arterial disease2006 · 24 citations
2Comparison of Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Ximelagatran or Warfarin2006 · 88 citations
3Observations of Alanine Aminotransferase and Aspartate Aminotransferase in THRIVE Studies Treated Orally with Ximelagatran2006 · 21 citations
4Management of acute myocardial infarction in patients presenting with ST-segment elevation2003 · 1,452 citations
5ACC/AHA Guidelines for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction: Executive Summary and Recommendations2000 · 4,502 citations